Clinical Trials Directory

Trials / Completed

CompletedNCT03467334

Infant Colic Treatment With Probiotics

Nutritional Intervention, Multicenter, Randomized, Blind, Parallel Groups Study to Assess the Effect of Consumption of Bifidobacterium Breve CECT7263 and Lactobacillus Fermentum CECT5716 on Infant Colic

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
156 (actual)
Sponsor
Mónica Olivares Martín; PhD · Industry
Sex
All
Age
3 Weeks – 12 Weeks
Healthy volunteers
Not accepted

Summary

This study evaluates the efficacy of Bifidobacterium breve CECT7263 and the mixture B. breve CECT7263/Lactobacillus fermentum CECT5716 in the treatment of infant colic. Group 1 will receive B. breve CECT7263 (2x10E8 CFU/day) one dose per day, group 2 will receive B. breve CECT7263 (1x10E8 CFU/day) and L. fermentum CECT5716 (1x10E8 CFU/day) in one dose per day, group 3 (control group) will receive simethicone 20 mg 4 times a day.

Detailed description

Infant colic affects between 3-40% depending on the different criteria used for diagnosis. Recent studies carried out in healthy infants have shown that the consumption of B. breve CECT7263 and L. fermentum CECT5716 during the first months of life are related to a lower risk to present episodes of crying characteristic of infantile colic. The objective of the present study is to compare the effect of B. brevis and B. brevis\\L mixture. fermentum with respect to simethicone. It is a multicenter, controlled, randomized, blind, parallel-group, 4-weeks nutritional intervention study which will be conducted in 18 public and private hospitals and health centers from Spain.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTB. breveBifidobacterium probiotic strain at 1E+08 cfu/day
DIETARY_SUPPLEMENTB. breve plus L. fermentumProbiotic combination at 2E+08 cfu/day
DRUGSimethicone 20 MGStandard treatment for infant colic

Timeline

Start date
2017-05-31
Primary completion
2019-06-15
Completion
2019-06-15
First posted
2018-03-16
Last updated
2019-07-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03467334. Inclusion in this directory is not an endorsement.